研究業績 Research achievements

  1. Kimura S, Takaoka Y, Sugano A. Increase in the number and duration of sleep episodes during class after reopening of schools following closure due to COVID-19. Kobe J Med Sci. 2022 Dec;68(1):E23-29.
  2. Shikata M, Chujo D, Enkaku A, Takikawa-Nishida A, Honoki H, Yamada-Matsukoshi S, Nakagawa-Yokoyama M, Kamigishi M, Inagawa S, Fujisaka S, Yagi K, Shibuya K, Fujii T, Tobe K. Perioperative C-peptide index is associated with the status of diabetes management after pancreatectomy. J Diabetes Investig. 2022 Oct;13(10):1685-1694.
  3. Sugano A, Takaoka Y, Kataguchi H, Ohta M, Kimura S, Araki M, Morinaga Y, Yamamoto Y. SARS-CoV-2 Omicron BA.2.75 variant may be much more infective than preexisting variants based on in silico model. Microorganisms 2022 Oct;10(10):2090.
  4. 中條大輔. 1型糖尿病に対する成因治療の可能性. 新潟県医師会報. 2022年8月;869:2-7.
  5. Yagi K, Imamura T, Tada H, Liu J, Miyamoto Y, Ohbatake A, Ito N, Shikata M, Enkaku A, Takikawa A, Honoki H, Fujisaka S, Chujo D, Origasa H, Kinugawa K, Tobe K. Fragmented QRS on electrocardiography as a predictor for diastolic cardiac dysfunction in type 2 diabetes. J Diabetes Investig. 2022 Jun;13(6):1052-1061.
  6. Takaoka Y, Sugano A, Morinaga Y, Ohta M, Miura K, Kataguchi H, Kumaoka M, Kimura S, Maniwa Y. Prediction of infectivity of SARS-CoV2: Mathematical model with analysis of docking simulation for spike proteins and angiotensin-converting enzyme 2. Microb Risk Anal. 2022 Jun;22:100227.
  7. 中條大輔(編集). 医学のあゆみ. 1型糖尿病-診療と研究の最前線. 2022年5月7日発刊. 医歯薬出版社
  8. Chujo D, Kurokawa T, Kawabe A, Takahashi N, Inagaki F, Shinohara K, Hagiwara S, Edamoto Y, Ohmagari N, Hinoshita F, Tajima T, Kajio H, Ohtsu H, Takemura N, Matsumoto S, Shimoda M. Allogeneic islet transplantation with monitoring of islet-specific cellular autoimmunity in a Japanese patient with type 1 diabetes: A case report. J Diabetes Investig. 2022 Apr;13(4):741-745.
  9. 中條大輔. 1型糖尿病の成因に対する治療の可能性. 日本臨床. 2022年4月;80(4):714-719
  10. Hagiyama M, Takeuchi F, Sugano A, Yoneshige A, Inoue T, Wada A, Kajiyama H, Takaoka Y, Sasaki K, Ito A. Indigo plant leaf extract inhibits the binding of SARS-CoV-2 spike protein to angiotensin-converting enzyme 2. Exp Ther Med. 2022 Feb;68(1);274.
  1. Chujo D, Kawabe A, Matsushita M, Tsutsumi C, Haseda F, Imagawa A, Hanafusa T, Ueki K, Kajio H, Yagi K, Tobe K, Shimoda M. Fulminant type 1 diabetes patients display high frequencies of IGRP-specific type 1 CD8+ T cells. Clin Immunol. 2021 Dec;233:108893.
  2. Shimoda M, Chujo D, Kurokawa T, Kawabe A, Takahashi N, Ito K, Maruyama K, Shinohara K, Ajima K, Sugahara Y, Takaki T, Kajio H, Yanase M, Hinohara C, Tokuhara M, Uemura Y, Edamoto Y, Takemura N, Matsumoto S, Kokudo N. Efficacy and safety of total pancreatectomy with islet autotransplantation: A clinical study in Japan. J Diabetes. 2021 Nov;13(11):940-942.
  3. 中條大輔. 1型糖尿病に対する免疫修飾療法の可能性. 医学のあゆみ. 2021年10月;276(5):463-467
  4. 中條大輔. 1型糖尿病における細胞性免疫異常〜病態と治療法開発の可能性〜. 月刊糖尿病. 2021年10月;13(6):13-17.
  5. Chujo D, Imagawa A, Yasuda K, Abiru N, Awata T, Fukui T, Ikegami H, Kawasaki E, Katsuki T, Kobayashi T, Kozawa J, Nagasawa K, Ohtsu H, Oikawa Y, Osawa H, Shimada A, Shimoda M, Takahashi K, Tsuchiya K, Tsujimoto T, Yasuda H, Hanafusa T, Kajio H. Japanese Type 1 Diabetes Database Study (TIDE-J): rationale and study design. Diabetol Int. 2021 Sep 6;13(1):288-294.
  6. Yagi K, Nagata Y, Yamagami T, Chujo D, Kamigishi M, Yokoyama-Nakagawa M, Shikata M, Enkaku A, Takikawa-Nishida A, Honoki H, Fujisaka S, Origasa H, Tobe K. High prevalence of fragmented QRS on electrocardiography in Japanese patients with diabetes irrespective of metabolic syndrome. J Diabetes Investig. 2021 Sep;12(9):1680-1688.
  7. Shinohara K, Chujo D, Tamura-Nakano M, Kurokawa T, Matsumoto S, Shimoda M. High-quality porcine islets isolated from aged miniature pigs. Xenotransplantation. 2021 May;28(3):e12675.
  8. Yagi K, Imamura T, Tada H, Chujo D, Liu J, Shima Y, Ohbatake A, Miyamoto Y, Okazaki S, Ito N, Nakano K, Shikata M, Enkaku A, Takikawa A, Honoki H, Fujisaka S, Origasa H, Tobe K. Diastolic Cardiac Function Improvement by Liraglutide Is Mainly Body Weight Reduction Dependent but Independently Contributes to B-Type Natriuretic Peptide Reduction in Patients with Type 2 Diabetes with Preserved Ejection Fraction. J Diabetes Res. 2021 Mar 27;2021:8838026.
  9. Honoki H, Yagi K, Tsuda S, Wada T, Enkaku A, Nakagawa-Yokoyama M, Kamigishi M, Shikata M, Takikawa-Nishida A, Fujisaka S, Chujo D, Sasaoka T, Nakashima A, Saito S, Tobe K. Type 1 diabetes woman with repeated miscarriages successfully gave birth after introducing an insulin pump with a predictive low glucose suspend feature. Diabetol Int. 2021 Mar 6;12(3):324-329.
  1. Chujo D, Kawabe A, Matsushita M, Takahashi N, Tsutsumi C, Haseda F, Imagawa A, Hanafusa T, Ueki K, Kajio H, Yagi K, Tobe K, Shimoda M. Distinct Phenotypes of Islet Antigen-Specific CD4+ T Cells Among the 3 Subtypes of Type 1 Diabetes. J Clin Endocrinol Metab. 2020 Oct 1;105(10):dgaa447.
  2. 中條大輔. CGMの種類と適応・費用がわからない!?. Diabetes Strategy. 2020年11月;10(4):19-25.
  3. 寺元 剛. 臨床研究法への対応と課題, そして期待. 薬理と治療. 2020年10月;48(10):1691-1694.
  4. 寺元 剛.連載 臨床研究のパラダイムシフト⑨ 指針の統合, ゲノム指針と臨床研究指針. Clinical Research Professionals. 2020年10月;80.81:4-8.
  5. Ueno K, Chujo D, Takahashi N, Ohsugi M, Ueki K, Kajio H. Patient Satisfaction and Clinical Efficacy of Flash Glucose Monitoring in Patients with Type 1 Diabetes: A Prospective, Single-Center, Single-Arm Study. Diabetes Ther. 2020 Aug;11(8):1883-1890.
  6. Terakawa A, Chujo D, Yasuda K, Ueno K, Nakamura T, Hamano S, Ohsugi M, Tanabe A, Ueki K, Kajio H. Maturity-Onset diabetes of the young type 5 treated with the glucagon-like peptide-1 receptor agonist: A case report. Medicine (Baltimore). 2020 Aug 28;99(35):e21939.
  7. 寺元 剛. 連載 臨床研究のパラダイムシフト⑧ 遠隔環境で倫理審査委員会を開催するということ. Clinical Research Professionals. 2020年6月;78:10-13.
  8. 中條大輔. 1型糖尿病に対する免疫学的介入の可能性. 糖尿病プラクティス. 2020年5月;37(3):312-315.
  9. 中條大輔. 1型糖尿病の成因−自己免疫–. 糖尿病プラクティス. 2020年3月;37(2):187-190.
  10. 寺元 剛. 連載 臨床研究のパラダイムシフト⑦ タイトルと研究の背景から研究計画を読み解いてみる. Clinical Research Professionals. 2020年2月;76:10-13.
  11. Honoki H, Yagi K, Kambara K, Chujo D, Shikata M, Enkaku A, Takikawa-Nishida A, Liu J, Fujisaka S, Tobe K. Anti-programmed death ligand 1 therapy-induced type 1 diabetes presenting with multiple islet-related autoantibodies. J Diabetes Investig. 2020 Jan;11(1):253-254.
  12. 中條大輔. 1型糖尿病の診断と病型. 糖尿病プラクティス. 2020年1月;37(1):48-51.